Dan Turner

Dan Turner

Président chez GC Aesthetics Plc

62 ans
Health Technology
Finance
Commercial Services

Profil

Dan K.
Turner
founded Montreux Equity Partners, Inc. in 1993, where he is working as Managing Director.
Mr. Turner also currently works at Global Consolidated Aesthetics Ltd., as Chairman, GC Aesthetics Plc, as Chairman, Crown Laboratories, Inc., as Director, NovaCardia, Inc., as Director, moksha8 Pharmaceuticals, Inc., as Director, Pure Life Renal, Inc., as Director, Woodside Priory School, as Director, and Montreux IV Associates IV LLC, as Director.
Mr. Turner also formerly worked at Renex Corp., as Chairman, Transcept Pharmaceuticals, Inc. (Old), as Director from 2003 to 2009, Peninsula Pharmaceuticals, Inc., as Director, Somaxon Pharmaceuticals, Inc., as Director from 2004 to 2008, Avantis Medical Systems, Inc., as Director, Orexigen Therapeutics, Inc., as Independent Director from 2005 to 2012, Cerexa, Inc., as Director, Glaukos Corp., as Director, Colorescience Corp., as Director, NeurogesX, Inc., as Director, Renal CarePartners, Inc., as Director, Tobira Therapeutics, Inc., as Director, Sequel Pharmaceuticals, Inc., as Director, Transcept Pharma, Inc., as Independent Director from 2009 to 2011, EPIRUS Biopharmaceuticals, Inc., as Director, Questcor Pharmaceuticals, Inc., as Principal, Pricewaterhouse LLP, as Principal, Oclassen Pharmaceuticals, Inc., as Chief Financial Officer from 1986 to 1990, and Berkeley VC International LLC, as Principal.
Mr. Turner received his undergraduate degree from California State University-Sacramento.

Postes actifs de Dan Turner

SociétésPosteDébut
Président -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Président -
Woodside Priory School Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Fondateur 09/12/2010
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Tous les postes actifs de Dan Turner

Anciens postes connus de Dan Turner

SociétésPosteFin
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Dan Turner

Formation de Dan Turner

California State University-Sacramento Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Dan Turner

Relations

100 +

Relations au 1er degré

29

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
GLAUKOS CORPORATION

Health Technology

EPIRUS BIOPHARMACEUTICALS, INC.

Health Technology

Entreprise privées26

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Health Services

Pricewaterhouse LLP

Commercial Services

Health Technology

Finance

Finance

Health Technology

Health Services

Health Technology

Retail Trade

Health Technology

Technology Services

Health Technology

Woodside Priory School

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Dan Turner